Prediabetes Conversion to Normoglycemia Is Superior Adding a Low-Carbohydrate and Energy Deficit Formula Diet to Lifestyle Intervention-A 12-Month Subanalysis of the ACOORH Trial
Overview
Authors
Affiliations
Lifestyle interventions have been shown to reverse hyperglycemia to normoglycemia. However, these effects are not long-lasting and are accompanied with high dropout rates. As formula diets have been shown to be simple in usage and effective in improving glycemic control, we hypothesised that adding a low-carbohydrate and energy deficit formula diet to a low-intensity lifestyle intervention is superior in reversing prediabetes compared with lifestyle intervention alone. In this predefined subanalysis of an international, multicenter randomised controlled trial ( (ACOORH) study (ID DRKS00006811)), 141 persons with prediabetes were randomised (1:2) into either a control group with lifestyle intervention only (CON, = 45) or a lifestyle intervention group accompanied with a formula diet (INT, = 96). Both groups were equipped with telemonitoring devices. INT received a low-carbohydrate formula diet substituting three meals/day (~1200 kcal/day) within the first week, two meals/day during week 2-4, and one meal/day during week 5-26 (1300-1500 kcal/day). Follow-up was performed after 52 weeks and 105 participants (75%, INT: = 74; CON: = 31) finished the 26-week intervention phase. Follow-up data after 52 weeks were available from 93 participants (66%, INT: = 65; CON: = 28). Compared with CON, significantly more INT participants converted to normoglycemia after 52 weeks (50% vs. 31%; < 0.05). The risk reduction led to a number-needed-to-treat of 5.3 for INT. Lifestyle intervention with a low-carbohydrate formula diet reduces prediabetes prevalence stronger than lifestyle intervention alone and is effective for type 2 diabetes prevention.
Alfaqih M, Ababneh E, Khader Y, Mhedat K, Sater M Biomolecules. 2025; 15(2).
PMID: 40001498 PMC: 11852472. DOI: 10.3390/biom15020195.
Meal replacements on obesity and leptin: a systematic review and meta-analysis.
Fatahi S, Fotros D, Sohouli M, Vahidshahi K, Rohani P, Guimaraes N Rev Endocr Metab Disord. 2024; 26(1):55-80.
PMID: 39433654 DOI: 10.1007/s11154-024-09918-5.
Ruseva A, Michalak W, Zhao Z, Fabricatore A, Hartaigh B, Umashanker D Obes Sci Pract. 2024; 10(1):e737.
PMID: 38332756 PMC: 10851954. DOI: 10.1002/osp4.737.
Kempf K, Dubois C, Arnold M, Amelung V, Leppert N, Altin S Nutrients. 2023; 15(18).
PMID: 37764738 PMC: 10534832. DOI: 10.3390/nu15183954.
A soy-yoghurt-honey product as a therapeutic functional food: mode of action and narrative review.
Berg A, McCarthy H Heliyon. 2022; 8(11):e11011.
PMID: 36353168 PMC: 9637671. DOI: 10.1016/j.heliyon.2022.e11011.